Gritstone Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Gritstone Oncology's estimated annual revenue is currently $46.5M per year.
- Gritstone Oncology received $92.7M in venture funding in September 2017.
- Gritstone Oncology's estimated revenue per employee is $199,571
- Gritstone Oncology's total funding is $396M.
- Gritstone Oncology's current valuation is $424.9M. (January 2022)
- Gritstone Oncology has 233 Employees.
- Gritstone Oncology grew their employee count by 2% last year.
Gritstone Oncology Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Gritstone Oncology?
Gritstone Oncology is a privately-held company headquartered in the San Francisco Bay Area with key functions located in Cambridge, Massachusetts and Pleasanton, California. We launched in October 2015, and since inception, have successfully raised two large, private financing rounds. We currently employ more than 60 professionals. We have brought together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to tackle fundamental challenges at the intersection of cancer genomics and immunotherapy. With our unique approach to immuno-oncology, we are developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors. We plan to combine these personalized neoantigen-targeted therapies with current immune checkpoint modulatory approaches to improve response rates and survival in patients with solid tumors.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
Gritstone Oncology News
... Agenus, Roche, Nouscom, Genocea Biosciences, Gritstone Oncology, Gilead Sciences, BioNTech, ISA Pharmaceutical, Vaccibody.
5TH ANNUAL MARKETSANDMARKETS NEXT-GEN IMMUNO-ONCOLOGY CONFERENCE ... Director, Molecular Biology and Sequencing, Gritstone Oncology, Inc
Gritstone Oncology (GRTS) Delivers Presentations Supporting Expertise in Neoantigen Vaccine Design and Delivery. April 12, 2022 4:35 PM.
12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (GRTS), a clinical-stage biotechnology company developing the next generation of ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Gritstone Oncology Funding
|2017-09-08||$92.7M||Undisclosed||Lilly Asia Ventures||Article|